
In experiments at the European Nuclear Research Center, a 'zeptoverse' scale, 100 billion times smaller than an atom, was reached.
AI-generated summary
The Large Hadron Collider at CERN performs high-energy particle collisions to study the fundamental building blocks of the universe.
According to BBC news, in experiments carried out at the Large Hadron Collider (LHC) at the European Center for Nuclear Research (CERN), physicists announced that they managed to receive signals from the smallest scale of nature examined to date.
In the study led by scientists from Cambridge University in England, this scale, called the "zepteuniverse", is shown to be the smallest scale ever examined in nature.
'100 BILLION TIMES SMALLER'
In the study, which recorded that a size of 100 billion times smaller than the atom was reached, it was stated that the "zepteuniverse" scale could help develop a new and more comprehensive theory of the functioning of the universe.
Dark matter, which cannot be seen directly and covers the largest part of the universe, can only be detected by the gravitational effect it exerts on its surroundings.
Researchers who wanted to solve this mystery examined sub-particles called "beauty quarks", which are particles smaller than the atom and released through high-energy collisions.
Thus, interactions of these particles, whose lifetime is less than one trillionth of a second, on a scale of one trillionth of a billionth of a meter were detected.
'WE ARE ON THE THRESHOLD OF THE ZEPTEUNVERSE'
Dr. from Cambridge University, who is the head of the data analysis team. In his statement about the study, Harry Cliff stated that these micro-sized particles are much more suitable for interacting with dark matter.
Cliff said, "We are on the threshold of the Zeptoverse. By watching the movements in this incredible little world, we can see how new particles behave. Now our next goal is to open the door wide and discover the unknown particles waiting for us inside." he said.
BUDGET OBSTACLE FROM ENGLAND TO THE PROJECT
While the 28 countries involved in the project agreed on a budget of 150 million pounds, which will increase the capacity of the LHCb detector by 10 times, the UK Research and Innovation Institute (UKRI) announced last year that it would withdraw the funding it provided to the project.
Professor Tim Gershon, leader of the international LHCb collaboration, said this decision put Britain's presence in the research at risk and that the country could be left out of historic discoveries.
Famous physicist Professor Brian Cox also harshly criticized the cut, arguing that Britain's stepping back from scientific leadership would damage its international reputation.
AI outlook — possibilities, not facts
LHCb detector capacity increase projection will continue
Likely · Within months

CERN researchers, led by the University of Cambridge, received signals from the 'zepto-universe' dimension, which is 100 billion times smaller than the atom. While the discovery of beauty quarks could shed light on dark matter, Britain's funding cut created controversy.

The research, conducted jointly by five US neuroscience laboratories, revealed that silocybin did not provide a permanent improvement in depression and anxiety in mice, thus bringing publication bias into question in the scientific world.

An international research team has detected, for the first time in the world, fossilized red blood cells in the bones of a 115-million-year-old Aratasaurus dinosaur. This discovery could reshape what is known about dinosaur metabolism and evolution.

MPFI Fitzpatrick Laboratory researchers reported detecting a 5-fold increase in the dendritic spines of neurons in the primary visual cortex in the first few days after eye opening. The study shows that instead of deleting weak connections, the brain creates new strong connections that process compatible signals. The findings may shed light on new methods of treating developmental brain disorders and neurological disorders.

Exin Therapeutics performed autonomous brain surgery on a mouse using Anthropic's Sonnet model. While artificial intelligence determines the gene therapy vector and dosage on its own, the operation has brought about ethical debates and questions of liability.

Cortical Labs researchers managed to direct the movements of a robot dog by integrating live brain cells grown in the laboratory into silicon chips. This is the first time biochip technology has been tested on a physical robotic system.